Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide.

• Managed 443 compound development programs (>250 IND/CTA enabling), with over 100 different sponsors, which led to 41 IND/CTA applications in 2009• Performed best-in-class productivity cycle times: FIA to FIH in 22 weeks• Dedicated Capacity Agreements with several major pharma customers• Greater than 2.5M sq ft of research space

• Results-driven reimbursement support for >60% of the biologics market• Designed and managed world’s largest safety registry ever – iPledge• Team of experts dedicated to risk management and Pharmacovigilance• Bi-coastal call center capabilities to deliver patient and physician support